Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial
Download the PDF here.
This post appeared first on investingnews.com
You May Also Like
Business News
China on Monday accused U.S. chipmaker Nvidia of violating its anti-monopoly law, a move likely to escalate already tense trade relations between the two...
Stock News
My recent discussions on the Market Misbehavior podcast have often included some comments on the interest rate environment, particularly the shape of the yield...
Business News
A rogue employee was responsible for hiding $151 million in delivery expenses over the course of nearly three years, Macy’s said Wednesday. In a...
Stock News
The first trading week in December started on a positive note, with the S&P 500 ($SPX) and Nasdaq Composite ($COMPQ) notching new all-time highs,...